Chimeric Therapeutics’ CHM CDH17 Granted FDA Fast Track Designation
Posted: 10 June 2025 Chimeric Therapeutics (ASX:CHM) announced that the US Food and Drug Administration (FDA) had granted Fast Track Designation to CHM CDH17. This designation was based on the FDA’s assessment of CHM CDH17’s potential to improve…
La Trobe University unveils AI Supercomputer for medical innovation
Posted: 4 June 2025 La Trobe University has “switched on” Australia’s first AI-powered medical innovation centre with NVIDIA DGX H200 systems. This has marked a major step in AI-driven medical and biotech research. Vice-Chancellor Professor Theo Farrell said,…
INOVIQ announces early ovarian cancer screening breakthrough
Posted: 4 June 2025 INOVIQ Limited announced groundbreaking results from its EXO-OC™ ovarian cancer test at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2025, in Chicago. The test achieved 77% sensitivity and 99.6%…
Cartherics to Present at the 2025 BIO International Convention
Posted: 2 June 2025 BioMelbourne Network is pleased to share that one of our valued members Cartherics Pty Ltd, will present at the upcoming 2025 BIO International Convention June 16-19 2025, in Boston Massachusetts. Catherics Chief Operating Officer,…
Spotlight on how lung cell mapping can help prevent respiratory pandemics
Posted: 28 May 2025 The COVID-19 pandemic demonstrated the urgent need for better understanding of how viruses interact with our lungs. That’s the focus of the Doherty Institute’s Associate Professor Ash Haque and his team’s work: using a…
Brandon Capital opens second funding round for its Cureator Incubator program
Posted: 26 May 2025 Brandon Capital has opened the second funding round for its Cureator Dementia and Cognitive Decline incubator program with up to $5 million for each project. The CUREator+ Dementia and Cognitive Decline incubator program is…
Connection, courage and change: Inside the 2025 BioMelbourne Network Connecting Women Lunch
More than 600 people filled the Grand Ballroom of the Sofitel Melbourne on Collins for BioMelbourne Network’s highly anticipated 2025 Connecting Women Lunch – a flagship celebration of women and people identifying as women across our health technology…
Federal Grant Boosts Dementia Research at Monash University
Posted: 13th May 2025 Monash University received $953,751 from the Federal Government’s Medical Research Future Fund to study human brain cells for potential dementia treatments. This grant enabled the Monash Institute of Pharmaceutical Sciences to “light up” human…
Breakthrough in Vaccine Technology Promises Long-Lasting Protection
Posted: 13th May 2025 A significant advancement in vaccine technology has been made by WEHI scientists, potentially leading to long-lasting vaccines against viruses and enhanced cancer therapies. The study, published in the Journal of Experimental Medicine, utilized a…
Buy Local Push with ‘Pathway to Market’ Program Opening for Homegrown Medtech Makers
Posted: 9 May 2025 MEDIA RELEASE Buy Local Push with ‘Pathway to Market’ Program Opening for Homegrown Medtech Makers With a focus on local procurement, MTPConnect has launched its Pathway to Market – Medtech Capability Uplift Program…
4D Medical Secured Major Contract with Intermountain Health for AI-Based Pulmonary Hypertension Analysis
Posted: 6th May 2025 4D Medical announced a significant agreement with Intermountain Health, a leading healthcare network based in Salt Lake City, Utah. The agreement saw 4D Medical’s advanced pulmonary hypertension analysis algorithm, powered by artificial intelligence (AI),…
VivaZome Therapeutics presents brain injury efficacy data at international exosome conference
Posted: 2nd May 2025 VivaZome Therapeutics Pty Ltd (“VivaZome”) have unveiled promising results at an international conference from their latest research on Traumatic Brain Injury (TBI) treatment. The findings, presented by Chief Scientific Officer Professor David Haylock at…
